MANE (Veradermics) NonCurrent Deferred Liabilities: $0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MANE Veradermics Inc MANE
12 GF Score
Price $109.49
! 1 Warning Sign
View Full Analysis

What is Veradermics NonCurrent Deferred Liabilities?

Veradermics MANE +3.25% 12 NonCurrent Deferred Liabilities is $0.00 Mil as of Mar. 2026. GuruFocus rates MANE with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Veradermics's non-current deferred liabilities for the quarter that ended in Mar. 2026 was $0.00 Mil.

Veradermics NonCurrent Deferred Liabilities Related Terms

Veradermics NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Veradermics's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veradermics NonCurrent Deferred Liabilities Chart

Veradermics Annual Data
Trend Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
0.00 0.00 0.00

Veradermics Quarterly Data
Dec23 Dec24 Mar25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
MANE
12GF Score
Veradermics Inc MANE
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $0.00 Mil mean?
Veradermics (MANE) has a NonCurrent Deferred Liabilities of $0.00 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Veradermics and its competitors.
Is Veradermics' NonCurrent Deferred Liabilities too high?
Veradermics' current NonCurrent Deferred Liabilities is $0.00 Mil. Overall, Veradermics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Veradermics' NonCurrent Deferred Liabilities compare to CAI and DNTH?
Veradermics' NonCurrent Deferred Liabilities of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Veradermics and its competitors. Veradermics's current NonCurrent Deferred Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veradermics stock overvalued right now?
Veradermics (MANE) has a current NonCurrent Deferred Liabilities of $0.00 Mil. The current NonCurrent Deferred Liabilities is $0.00 Mil. Veradermics' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Veradermics (MANE), the current NonCurrent Deferred Liabilities is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veradermics Business Description

Address 470 James Street, New Haven, CT, USA, 06513
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
12GF Score

Get the complete analysis for MANE

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$109.49
Price